Pharma Focus Asia
KP - Sustainable Packaging Solutions

GE Healthcare Life Sciences to Build New Manufacturing Facility in Switzerland

Introduction:

GE Healthcare Life Sciences is building a new manufacturing facility, in the new Signy Park, in Grens, Switzerland.

Features:

The main focus of the 7,360 square meter facility will be the manufacture of single-use kits for the Sepax and Sefia cell processing systems.

The Sepax and Sefia cell processing systems are intended to automate processing steps during cell and gene therapy development.

Through the use of a separation chamber manifolded to cell bags, these kits enable a variety of protocols including Cellwash, Culture Wash, Adipose protocols, Dilution, Cell Harvesting, and Expansion.

However, it will also house a Center of Excellence that will include advanced cell and gene therapy manufacturing facilities, as well as an R&D  team.

The facility will also serve as a base for European customer training and educational initiatives.

The site is expected to be fully operational in 2022 and will be able to house up to 200 employees.

Specifications:

NameGE Healthcare Life Sciences
TypeConstruction
LocationSwitzerland
Latest Issue
Get instant
access to our latest e-book
MFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Gibco Adherent Kidney Media PanelCPHI Korea 2024Equinix accelerated medical research...CHEMICAL INDONESIA 2024Thermofisher - Antibody Therapeutic PolishingINALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024
Searching for an end-to-end patient tech solution?